Top News
BlackRock Acquires 5.01% Stake in HLB: What This Means for Investors
BlackRock acquires a 5.01% stake in HLB, becoming the second-largest shareholder, signaling confidence in HLB's liver cancer drug.
- Our Sponsors Ad -
